Fig. 2

Activation and maturation marker after S1P. a Sorted slanDCs (A–E) of healthy donors were cultured in the absence (without) or presence of 2 or 200 nM S1P. Expression of activation and maturation surface markers was analyzed. b Sorted slanDCs (A–E) of FTY-treated MS patients were cultured in the absence (without) or presence of 20 or 200 nM S1P. Expression of activation and maturation surface markers was analyzed. Mean values ± SEM of eight individual experiments are presented. Bonferroni’s correction was used. Asterisks indicate statistically significant difference (*p < 0.05)